HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.

AbstractOBJECTIVE:
We have examined the association between the incidence of coronary heart disease (CHD) and plasma high density lipoprotein (HDL) cholesterol, apolipoprotein A-I (apoA-I), and 2 HDL fractions, lipoprotein A-I and lipoprotein A-I:A-II.
METHODS AND RESULTS:
These parameters were measured in subjects recruited in France and in Northern Ireland in the Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study, a prospective cohort study. Among the subjects free of CHD on entry, 176 in France and 113 in Northern Ireland suffered an ischemic attack (CHD patients) during the 5-year follow-up, whereas 6612 French and 2172 Northern Irish men showed no CHD symptoms (CHD-free subjects). All 4 HDL parameter levels were lower in CHD patients than in CHD-free subjects. After the cohort was divided into quintiles based on the distribution of HDL parameter levels, a significant (P<0.0001) linear increase in relative risk was observed for each HDL parameter level. However, regression logistic analyses showed that apoA-I was the strongest predictor (more powerful than HDL cholesterol) and that lipoprotein A-I and lipoprotein A-I:A-II did not supplement apoA-I in predicting CHD.
CONCLUSIONS:
Among the parameters related to HDL, apoA-I appears to be the strongest independent risk factor.
AuthorsGérald Luc, Jean-Marie Bard, Jean Ferrières, Alun Evans, Philippe Amouyel, Dominique Arveiler, Jean-Charles Fruchart, Pierre Ducimetière
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 22 Issue 7 Pg. 1155-61 (Jul 01 2002) ISSN: 1524-4636 [Electronic] United States
PMID12117731 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Validation Study)
Chemical References
  • Apolipoprotein A-I
  • Cholesterol, HDL
  • Lipoprotein(a)
  • lipoprotein A-II
  • lipoprotein A-I
Topics
  • Angina Pectoris (blood, diagnosis, epidemiology)
  • Apolipoprotein A-I (blood)
  • Cholesterol, HDL (blood)
  • Cohort Studies
  • Coronary Disease (blood, diagnosis, epidemiology)
  • France (epidemiology)
  • Humans
  • Lipoprotein(a) (analogs & derivatives, blood)
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, epidemiology)
  • Northern Ireland (epidemiology)
  • Predictive Value of Tests
  • Prospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: